https://it.marketscreener.com/quotazioni/azione/NEUROSENSE-THERAPEUTICS-L-130483704/attualita/Neurosense-riceve-la-conferma-da-parte-della-Fda-degli-Stati-Uniti-della-strategia-Cmc-per-Primec-i-45355501/?utm_source=telegram&utm_medium=social&utm_campaign=share